CLINICAL FEATURES OF POSTCOVID SYNDROME

Abstract

There is no common understanding of the clinical picture of post-ovoid syndrome. The American regulator CDC suggests highlighting (A) persistent symptoms and conditions that begin during acute COVID-19 disease; (B) first-time late complications after an asymptomatic disease or a period of acute symptom relief or remission; (C) the evolution of symptoms and conditions that include some persistent symptoms (for example, shortness of breath) with the addition of new symptoms or conditions over time (e.g. cognitive difficulties). Some manifestations may have similarities with other post-viral syndromes, such as myalgic encephalomyelitis/chronic fatigue syndrome, dysautonomia (for example, postural orthostatic tachycardia syndrome) or mast cell activation syndrome.